Health centers say the Trump administration’s final rule, released today, requiring them to pass their 340B saving on insulin and epinephrine auto-injectors to low-income patients will do more harm than good. | Source: Shutterstock
HRSA Releases 340B Insulin Final Rule Over Health Centers’ Strong Objections
The U.S. Health Resources and Services Administration (HRSA) this morning released a final rule to implement the Trump administration’s controversial executive order requiring community health centers to pass their 340B program savings on insulin and epinephrine autoinjectors to low-income, uninsured, and underinsured patients.
Health centers argued, but could not persuade the administration, that the rule should have been withdrawn. They said Trump’s order and the rule fundamentally misunderstand how health centers and the 340B program work, and would do more harm than good if implemented.
The U.S. Health Resources and Services Administration (HRSA) this morning released a final rule to implement the Trump administration’s controversial executive order requiring community health centers to pass their 340B program savings on insulin and epinephrine autoinjectors to low-income, uninsured, and underinsured patients.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
